| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 09/19/2002 | WO2002072540A2 Improved methods of ortho alkylation |
| 09/19/2002 | WO2002072524A2 Method for producing vinyl, aryl and heteroaryl acetic acids and derivatives thereof |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020133039 Reduction in presence of organtin hydride and Lewis acids |
| 09/19/2002 | US20020132852 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2440295A1 Method for producing vinyl, aryl and heteroaryl acetic acids and derivatives thereof |
| 09/19/2002 | CA2437755A1 Improved methods of ortho alkylation |
| 09/18/2002 | EP1241174A1 Chiral ligands for asymmetric synthesis |
| 09/18/2002 | EP1241159A1 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
| 09/18/2002 | EP1240941A2 Copper-aluminum mixed oxide catalyst, its preparation and use thereof |
| 09/18/2002 | EP1240352A2 Molecules derived from mechanism based drug design |
| 09/18/2002 | EP1240152A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 09/18/2002 | EP1240132A1 Adamantane derivatives |
| 09/18/2002 | EP1239949A1 New functionalized polymeric reagents |
| 09/18/2002 | EP1036059B1 Adamantane derivatives |
| 09/18/2002 | EP0888322B1 Electrophilic ketones for the treatment of herpesvirus infections |
| 09/18/2002 | EP0764158B1 Benzopyrans and their use as therapeutic agents |
| 09/18/2002 | CN1370143A Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 09/18/2002 | CN1370142A Nsigma long chain acyllysine crystals, process for producing same and cosmetics contg. same |
| 09/17/2002 | US6452037 Carbonylated, oligoanilinated derivatives; antitumor agents; photosensitizers transforming molecular oxygen into singlet oxygen; bioavailable |
| 09/17/2002 | US6452012 3-phenyl-2,6-dioxopiperidin-3-ylpropionamide derivatives and method for preparing same |
| 09/17/2002 | US6451843 Arylphenyl-substituted cyclic keto enols |
| 09/17/2002 | US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders |
| 09/17/2002 | CA2339311C Process for preparing improved nickel catalysts for use in hydrogenation reactions |
| 09/17/2002 | CA2158622C Cosmetic compositions containing a lipidic compound of ceramid type and a fatty peptide, and their uses |
| 09/12/2002 | WO2002070020A2 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 09/12/2002 | US20020128509 Process for synthesis of enantiomerically enriched beta-amino acids |
| 09/12/2002 | US20020128501 Particularly effective in Ru-catalyzed asymmetric hydrogenation of beta-ketoesters to beta-hydroxyesters and ruthenium-catalyzed asymmetric hydrogenation of enamides to beta amino acids; catalyst selectivity |
| 09/12/2002 | US20020128495 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof |
| 09/12/2002 | US20020128486 Phosphinite-oxazolines and metal complexes |
| 09/12/2002 | US20020128451 Phthalamide-lanthanide complexes for use as luminescent markers |
| 09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 09/12/2002 | US20020128231 Aryl-indane compounds |
| 09/12/2002 | US20020127605 Cyclophilin compound for use in the treatment of infections, nervous system, skin, ischemic and vision disorders |
| 09/12/2002 | US20020127202 Compounds and compositions for delivering active agents |
| 09/12/2002 | DE10111262A1 Verfahren zur Herstellung von Vinyl- Aryl- und Heteroarylessigsäuren und ihrer Devivate Process for the preparation of vinyl aryl and heteroaryl and its Devivate |
| 09/12/2002 | CA2710031A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 09/12/2002 | CA2709871A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 09/11/2002 | EP1237857A1 New phenalkyloxy-phenyl derivatives |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP0973729B1 A process for the preparation of 4-bromomethyl diphenyl compounds |
| 09/11/2002 | EP0912504B1 Oxazolidine ester |
| 09/11/2002 | CN1368953A Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha |
| 09/11/2002 | CN1368946A New selective retinoid agonists |
| 09/11/2002 | CN1090637C Cross-link cinnamic acid derivative and its preparation method |
| 09/10/2002 | US6448402 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol |
| 09/10/2002 | US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein |
| 09/10/2002 | US6448290 Prostaglandin e2 antagonist or agonist; inhibition of uterine contraction, analgesics, antidiarrheals, sleep inducers, increasing vesical capacity, cathartic, suppression of gastric acid secretion, antihypertensive, diuretic agents |
| 09/10/2002 | US6448278 Antiscarring agent |
| 09/10/2002 | US6448254 Substituted amides, their production and their use |
| 09/10/2002 | US6447815 Heated alcohol extraction of herbs |
| 09/06/2002 | WO2002068393A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/06/2002 | WO2002068380A1 Synthetic excitatory amino acids |
| 09/06/2002 | WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 09/06/2002 | WO2002036559A3 Process for the production of amides |
| 09/06/2002 | CA2434666A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/05/2002 | US20020123648 Containing an acid radical in such amount that the solubility of lysine therein has been increased; storage stability |
| 09/05/2002 | US20020123528 Alkynyl amides and their therapeutic applications |
| 09/05/2002 | DE10109856A1 Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus |
| 09/04/2002 | EP1236711A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 09/04/2002 | EP1236710A2 Process for making carboxylic amides |
| 09/04/2002 | EP1235790A2 Methods for producing 2-(2-hydroxyphenyl)-2-(alkoxyimino)-n-methylacetamide derivatives |
| 09/04/2002 | EP1235787A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 09/04/2002 | EP1235786A2 Method for the preparation of enantiomerically enriched compounds |
| 09/04/2002 | EP1149066A4 Method of preparing alkylated salicylamides |
| 09/04/2002 | CN1090173C Concentration method of aqueous acrylamide solution |
| 09/04/2002 | CN1090172C Process for producing purified terephthalic acid |
| 09/04/2002 | CN1090051C Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on amides |
| 09/04/2002 | CN1090050C Device for stirring and aerating liquid and eliminating foam in vat for treating this liquid |
| 09/04/2002 | CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 09/04/2002 | CN1090019C 组合物 The composition |
| 09/03/2002 | US6444832 Osteoporosis |
| 09/03/2002 | US6444827 From beta-methyl l-aspartate via chemical intermediate; efficiency; antidiabetic agents |
| 09/03/2002 | US6444702 Central nervous system disorders |
| 08/29/2002 | WO2002066436A1 Process for preparing 2-(4-chlorobenzolamino) -3-[2(1h) -quinolinon-4-yl]proprionic acid |
| 08/29/2002 | WO2002066432A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 08/29/2002 | WO2002066415A2 Non-steroidal modulators of estrogen receptors |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002002520A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2002002506A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
| 08/29/2002 | WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 08/29/2002 | US20020120137 FXR modulators |
| 08/29/2002 | US20020120096 Capable of stably fixing a water-soluble polymer onto a surface structure by taking advantage of intermolecular interaction, thereby enabling the water-soluble polymer to be carried thereon without giving any damage |
| 08/29/2002 | US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 08/29/2002 | US20020120009 Compounds and compositions for delivering active agents |
| 08/29/2002 | US20020120007 Benzamide inhibitors of factor Xa |
| 08/29/2002 | US20020119994 LFA-1 Antagonist compounds |
| 08/29/2002 | US20020119953 Sickle cell anemia |
| 08/29/2002 | US20020119910 Drug delivery |
| 08/29/2002 | DE10108307A1 Substituierte Propan-1,3-diamin-Derivate Substituted propane-1,3-diamine derivatives |
| 08/29/2002 | DE10107227A1 Verfahren zur Herstellung von 4-substituierten 2-Alkyl- und 2-Alkoxylbiphenylen A process for the preparation of 4-substituted 2-alkyl and 2-Alkoxylbiphenylen |
| 08/28/2002 | EP1234816A1 Scyphostatin analogues as SMase inhibitors |
| 08/28/2002 | EP1233669A2 Blocking an ethylene response in plants using cyclopropene derivatives |
| 08/28/2002 | EP1140956B1 Ligands and complexes for enantioselective hydrogenation |